Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
05/26/2016
|
SRPT |
|
PDUFA |
Other |
Fast Track, Orphan Drug, Priority Review, Rare Pediatric Disease |
|
05/26/2016
|
SRPT |
|
PDUFA |
Other |
Fast Track, Orphan Drug, Priority Review, Rare Pediatric Disease |
|
05/29/2016
|
ICPT |
|
PDUFA |
Other |
Accelerated Approval |
|
Q2 2016
|
TNXP |
|
Phase 2 Results |
Neurology |
None |
|
06/01/2016
|
AAAP |
|
PDUFA |
Oncology |
None, Orphan Drug, Priority Review |
|
H2 2016
|
RETA |
|
Phase 2 Results |
Cardiovascular |
Orphan Drug |
|
06/28/2016
|
LPCN |
|
PDUFA |
Endocrine |
None |
|
Q2 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q2 2016
|
ABUS |
|
Phase 2 Results |
Infectious Disease |
None |
|
Q2 2016
|
PRTK |
|
Phase 3 Results |
Infectious Disease |
Fast Track |
|